FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Rehiring Freedom of Information Staff

[ Price : $8.95]

FDA rehires some Freedom of Information office workers who were terminated under White House-mandated reduction-in-force cuts.

FDA Withdraws and Reissues 2 Guidances

[ Price : $8.95]

FDA says it is withdrawing two recent final guidances on cell- and tissue-based products and reissuing them in draft form to add c...

Petition Seeks to Restrict Da Vinci Off-Label Use

[ Price : $8.95]

A citizen petition asks FDA to restrict the off-label use of the Da Vinci Robotic System and video-assisted thoracoscopy devices t...

Vanda Tradipitant Scheduling Order Out

[ Price : $8.95]

The FDA Office of Scientific Integrity publishes a scheduling order for Vandas request for a hearing on a proposed CDER order to d...

FDA Rehiring Some Travel Support Staff

[ Price : $8.95]

The Associated Press reports FDA is attempting to rehire some travel support, food scientist, and Freedom of Information Act staff...

FDA Approves Element Science Wearable Defibrillator

[ Price : $8.95]

FDA approves the Element Science PMA for its Jewel Patch wearable cardioverter defibrillator.

Edwards Expands SAPIEN for Asymptomatic Patients

[ Price : $8.95]

FDA approves Edwards Lifesciences' SAPIEN 3 transcatheter aortic valve replacement platform for patients with severe aortic stenos...

Semaglutide Wins in Steatohepatitis, Fibrosis

[ Price : $8.95]

A Phase 3 trial funded by Novo Nordisk showed that its Ozempic/Wegovy outperformed placebo in patients with steatohepatitis and fi...

Drug Safety Monitoring Hurt by FDA Staff Cuts: Post

[ Price : $8.95]

Chemistry & Engineering News reports that reductions in CDER Division of Drug Information staff are affecting FDAs ability to main...

Placebo-controlled Trials Needed for Vaccines: HHS

[ Price : $8.95]

A self-described radical HHS policy now requires all new vaccines to be evaluated in placebo-controlled trials before theyre licen...